Jiangsu ChengXing Phosph-Chemicals Co., Ltd. (SHA:600078)
China · Delayed Price · Currency is CNY 10.89
-0.24 (-2.16%)
Sep 10, 2026, 3:00 PM CST
SHA:600078 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,888 | 3,503 | 3,230 | 3,032 | 4,465 | 3,055 |
Other Revenue | 69.57 | 93.67 | 125.67 | 68.99 | 72.55 | 278.87 |
| 3,958 | 3,596 | 3,356 | 3,101 | 4,538 | 3,333 | |
Revenue Growth | 12.60% | 7.16% | 8.22% | -31.66% | 36.12% | 6.28% |
Cost of Revenue | 3,287 | 3,172 | 3,147 | 2,798 | 3,550 | 2,664 |
Gross Profit | 670.87 | 424.26 | 209.32 | 303.24 | 987.72 | 669.89 |
Selling, General & Admin | 247.23 | 219.8 | 209.99 | 196.81 | 188.84 | 135.18 |
Research & Development | 4.76 | 6.92 | 8.87 | 6.31 | 0.4 | - |
Other Operating Expenses | 34.53 | 35.91 | 34.14 | 35.59 | 53.91 | -8.69 |
Operating Expenses | 286.44 | 262.63 | 253.31 | 236.22 | 256.62 | 143.83 |
Operating Income | 384.44 | 161.63 | -43.99 | 67.02 | 731.1 | 526.06 |
Interest Expense | -79.92 | -102.37 | -119.62 | -115.26 | -126.54 | -206.72 |
Interest & Investment Income | 10.19 | 43.51 | 45.06 | 55.47 | 61.69 | 62.39 |
Currency Exchange Gain (Loss) | -4.2 | 1.69 | 5.87 | 5.47 | 17.87 | -2.75 |
Other Non Operating Income (Expenses) | 0.09 | 0.24 | -14.04 | -1.11 | 227.65 | 1,894 |
EBT Excluding Unusual Items | 310.59 | 104.69 | -126.72 | 11.58 | 911.76 | 2,273 |
Gain (Loss) on Sale of Assets | 3.36 | 38.19 | 1.39 | 5.6 | 0 | -1.52 |
Asset Writedown | - | - | -3.12 | - | - | -0.78 |
Legal Settlements | - | - | -25.95 | -0.09 | -5.1 | -68.39 |
Other Unusual Items | -7.98 | -7.42 | -1.86 | -3.43 | -32.79 | -42.54 |
Pretax Income | 305.97 | 135.47 | -156.25 | 13.67 | 873.88 | 2,160 |
Income Tax Expense | 82.1 | 36.68 | -21.49 | -16.87 | 92.99 | 25.31 |
Earnings From Continuing Operations | 223.87 | 98.79 | -134.76 | 30.54 | 780.89 | 2,135 |
Minority Interest in Earnings | -116.32 | -90.32 | -64.13 | -91.37 | -259.12 | -119.64 |
Net Income | 107.54 | 8.47 | -198.9 | -60.83 | 521.77 | 2,015 |
Net Income to Common | 107.54 | 8.47 | -198.9 | -60.83 | 521.77 | 2,015 |
Net Income Growth | - | - | - | - | -74.11% | - |
Shares Outstanding (Basic) | 674 | 667 | 663 | 663 | 663 | 663 |
Shares Outstanding (Diluted) | 674 | 667 | 663 | 663 | 663 | 663 |
Shares Change | 2.10% | 0.69% | -0.01% | 0.01% | -0.05% | -0.01% |
EPS (Basic) | 0.16 | 0.01 | -0.30 | -0.09 | 0.79 | 3.04 |
EPS (Diluted) | 0.16 | 0.01 | -0.30 | -0.09 | 0.79 | 3.04 |
EPS Growth | - | - | - | - | -74.09% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 288.38 | 299.79 | 113.88 | 468.15 | 344.15 | 452.73 |
Free Cash Flow Per Share | 0.43 | 0.45 | 0.17 | 0.71 | 0.52 | 0.68 |
Dividend Per Share | - | - | - | 0.031 | 0.080 | - |
Dividend Growth | - | - | - | -61.25% | - | - |
Gross Margin | 16.95% | 11.80% | 6.24% | 9.78% | 21.77% | 20.10% |
Operating Margin | 9.71% | 4.49% | -1.31% | 2.16% | 16.11% | 15.78% |
Profit Margin | 2.72% | 0.24% | -5.93% | -1.96% | 11.50% | 60.46% |
Free Cash Flow Margin | 7.29% | 8.34% | 3.39% | 15.10% | 7.58% | 13.58% |
EBITDA | 591.45 | 381 | 205.43 | 330.77 | 992.53 | 794.82 |
EBITDA Margin | 14.94% | 10.59% | 6.12% | 10.67% | 21.87% | 23.84% |
D&A For EBITDA | 207.01 | 219.38 | 249.42 | 263.75 | 261.43 | 268.76 |
EBIT | 384.44 | 161.63 | -43.99 | 67.02 | 731.1 | 526.06 |
EBIT Margin | 9.71% | 4.49% | -1.31% | 2.16% | 16.11% | 15.78% |
Effective Tax Rate | 26.83% | 27.07% | - | - | 10.64% | 1.17% |
Revenue as Reported | 3,958 | 3,596 | 3,356 | 3,101 | 4,538 | 3,333 |